Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells.
Probiotics, defined as live microbial food supplements which improve the health of the host, have obtained increasing medical importance. In the intestine they may prevent the overgrowth of pathogenic bacteria, increase the resistance of the gut to invasion by pathogens and ameliorate disease processes by inducting the secretion of soluble factors such as cytokines and antimicrobial beta-peptides. One important class of human antimicrobial peptides is the family of defensins. Human beta-defensin 2 (HBD-2) is a major inducible peptide which plays an important role in host defense and represents a link between innate and adaptive immune responses. This linkage is in part mediated through the recognition of conserved bacterial products or bacteria by Toll-like receptors (TLRs). The aim of this study was to investigate the effects of Lactobacillus plantarum on intestinal epithelial cells. We found that Caco-2 cells exposed to L. plantarum bacteria significantly induced HBD-2 mRNA expression and HBD-2 secretion in a dose- (16+/-1.4 pg/ml and 31.5+/-2.3 pg/ml at MOI 10 and 50, respectively) and time-dependent manner, but not HBD-3, compared to controls; in addition, when LPS was added to cells for 48 h, the interleukin (IL)-23 secretion (850+/-5.4 pg/ml) and IL-23 mRNA expression increased; while it was reduced when LPS was cocultured with L. plantarum (330+/-4.2 pg/ml). The L. plantarum-induced increase in HBD-2 expression is inhibited by anti-TLR-2 neutralizing antibodies, in the same way the pre-treatment with the anti-TLR-2 antibody inhibited the production of IL-23 induced by LPS in Caco-2 cells. The results of our study help to achieve a better understanding of how the intestinal epithelium participates in the innate immune response to commensal bacteria and pathogens in the gut.
Paolillo
Rossella
R
Department of Experimental Medicine, Section of Microbiology and Clinical Microbiology, Faculty of Medicine and Surgery-Second University of Naples, Naples, Italy.
Romano Carratelli
Caterina
C
Sorrentino
Sabato
S
Mazzola
Nello
N
Rizzo
Antonietta
A
D000911:Antibodies, Monoclonal / Q000494:pharmacology; D018938:Caco-2 Cells; D002470:Cell Survival; D005136:Eye Proteins; D050556:Fatty Acid-Binding Proteins; D006801:Humans; D007155:Immunologic Factors / Q000378:metabolism*; D053759:Interleukin-23 / Q000378:metabolism; D007413:Intestinal Mucosa / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology*; D048191:Lactiplantibacillus plantarum; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors / Q000494:pharmacology; D009419:Nerve Tissue Proteins; D019936:Probiotics / Q000494:pharmacology*; D051195:Toll-Like Receptor 2 / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism; D015854:Up-Regulation; D023083:beta-Defensins / Q000378:metabolism
D000911:Antibodies, Monoclonal; D005136:Eye Proteins; C107356:Fabp5 protein, rat; D050556:Fatty Acid-Binding Proteins; D007155:Immunologic Factors; D053759:Interleukin-23; D008070:Lipopolysaccharides; D009419:Nerve Tissue Proteins; D051195:Toll-Like Receptor 2; D023083:beta-Defensins